Sonoma Pharmaceuticals Inc Financial Flexibility Index
Sonoma Pharmaceuticals Inc financial flexibility index. Sonoma Pharmaceuticals Inc (SNOA) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of $-647.00K (operating CF $-649.00K minus capex $2.00K) represents 0% of total liabilities ($11.51 Million). See SNOA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sonoma Pharmaceuticals Inc (2005–2026)
Financial flexibility index of Sonoma Pharmaceuticals Inc from 2005 to 2026. Historical Financial Flexibility Index trend for Sonoma Pharmaceuticals Inc across 22 annual periods. Check SNOA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Sonoma Pharmaceuticals Inc Financial Flexibility Index by Year (2005–2026)
Sonoma Pharmaceuticals Inc financial flexibility index by year from 2005 to 2026. Year-by-year free cash flow to debt coverage for Sonoma Pharmaceuticals Inc. For the full cash flow conversion analysis, see Sonoma Pharmaceuticals Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -0.34x | $-3.74 Million | $-3.93 Million | $10.87 Million | ▼ -39849.3% |
| 2025 | 0.00x | $-8.00K | $-88.00K | $9.28 Million | ▲ +99.7% |
| 2024 | -0.28x | $-2.38 Million | $-2.40 Million | $8.60 Million | ▲ +61.2% |
| 2023 | -0.71x | $-5.88 Million | $-6.15 Million | $8.25 Million | ▼ -75.9% |
| 2022 | -0.41x | $-4.11 Million | $-4.25 Million | $10.15 Million | ▼ -21.9% |
| 2021 | -0.33x | $-3.20 Million | $-3.38 Million | $9.62 Million | ▲ +32.3% |
| 2020 | -0.49x | $-4.38 Million | $-4.59 Million | $8.94 Million | ▲ +83.3% |
| 2019 | -2.93x | $-11.62 Million | $-11.72 Million | $3.96 Million | ▲ +7.1% |
| 2018 | -3.16x | $-12.25 Million | $-12.44 Million | $3.88 Million | ▼ -63.6% |
| 2017 | -1.93x | $-7.77 Million | $-8.17 Million | $4.03 Million | ▲ +15.9% |
| 2016 | -2.29x | $-8.40 Million | $-8.75 Million | $3.66 Million | ▼ -4.8% |
| 2015 | -2.19x | $-6.55 Million | $-6.69 Million | $2.99 Million | ▼ -335.7% |
| 2014 | -0.50x | $-4.39 Million | $-4.89 Million | $8.73 Million | ▼ -403.0% |
| 2013 | 0.17x | $1.41 Million | $1.15 Million | $8.48 Million | ▲ +139.1% |
| 2012 | -0.42x | $-3.70 Million | $-4.03 Million | $8.71 Million | ▲ +30.5% |
| 2011 | -0.61x | $-4.25 Million | $-4.43 Million | $6.96 Million | ▲ +70.2% |
| 2010 | -2.05x | $-6.50 Million | $-6.64 Million | $3.17 Million | ▲ +60.4% |
| 2009 | -5.17x | $-16.44 Million | $-16.83 Million | $3.18 Million | ▼ -151.6% |
| 2008 | -2.06x | $-16.83 Million | $-17.45 Million | $8.18 Million | ▼ -44.0% |
| 2007 | -1.43x | $-17.21 Million | $-18.08 Million | $12.05 Million | ▲ +61.9% |
| 2006 | -3.75x | $-20.05 Million | $-20.52 Million | $5.35 Million | ▼ -42.1% |
| 2005 | -2.64x | $-12.49 Million | $-13.53 Million | $4.74 Million | — |